The biopharma patent cliff: 9 drugs losing exclusivity by the end of 2023
Mass layoffs continue across the biotech sector
Roche posts interim TIGIT overall survival data after 'inadvertent disclosure'
Novartis to lay off another 100-plus employees at US HQ as global restructuring rolls on
*please scroll down for all the latest news*